Clinical Trials Logo

Ophthalmic Solutions clinical trials

View clinical trials related to Ophthalmic Solutions.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05936489 Completed - Presbyopia Clinical Trials

Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia

Start date: July 6, 2023
Phase: Phase 1
Study type: Interventional

This is a single-center, open-label, randomized study to assess the plasma pharmacokinetic profile of LNZ101 and LNZ100.

NCT ID: NCT03198000 Completed - Clinical trials for Ophthalmic Solutions

A Study to Evaluate the Efficacy of Investigational OTC Eye Drops

Start date: June 28, 2017
Phase: Phase 3
Study type: Interventional

This is a single center, double-blinded study designed to demonstrate the therapeutic equivalence of over-the-counter eye drops in healthy adults with red eyes.

NCT ID: NCT02697318 Completed - Glaucoma Clinical Trials

Evaluation of a New Method for Instilling Eye Drops

Start date: May 2016
Phase: Early Phase 1
Study type: Interventional

The purpose of this project is to demonstrate that there is a new easier method to instill eye drops in ones own eye that is as effective as applying a drop directly to their open eye. The benefits of this new method include better medication compliance and reduced patient anxiety from instilling their eye drops. This secondary benefit should remove the "approach-avoidance response" that prompts some patients to delay or give-up on instilling their drops just to avoid the angst and frustration produced by the challenge. The new method involves the patient instilling the eye drop onto their closed eyelid and then blinking the eye drop into their eye. We aim to show that this method has a similar therapeutic effect as the routine administration of an eye drop to an open eye.